Switzerland· 69990005
Eltrombopag Accord
A eltrombopag product containing eltrombopagum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Eltrombopag is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BX05 (eltrombopag), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Eltrombopag · ATC B02BX05
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of eltrombopag costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- Switzerland: $38.37 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Eltrombopag · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$38.37
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- eltrombopagum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B02BX05
- ATC class
- Eltrombopag
- Defined daily dose
- 50 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680699900053Blist 28 StkCHF 874.65
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
175 interactions on record for eltrombopag.
Graded by severity as the source publishes them — 20 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Eltrombopag · interactions on record
175 records
- 20 severe
- 153 moderate
- 2 minor
Most severe, free to view
- EluxadolineA07DA06severe
- BerotralstatB06AC06severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Eltrombopag in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEltrombopag Abdi 50 mg filmomhulde tablettenAbdi Farma GmbH
- SpainELTROMBOPAG ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- SwedenEltrombopag Accord 50 mg Filmdragerad tablettAccord Healthcare S.L.U.
- PolandEltrombopag AccordAccord Healthcare S.L.U.
- NorwayEltrombopag AccordAccord Healthcare S.L.U.
- IrelandEltrombopag Krka 50 mg film-coated tabletsKRKA, d.d., Novo mesto
- United StatesELTROMBOPAGCamber Pharmaceuticals, Inc.
- United KingdomEltrombopag 25mg tabletsWockhardt UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Elrevolan, Eltrombopag +pharma
- Belgium · Eltrombopag Krka
- Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
- Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
- Czechia · Eltrombopag Abdi, Eltrombopag Krka
- Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
- Denmark · Eltrombopag Glenmark, Eltrombopag Krka
- Estonia · Eltrombopag Krka, Eltrombopag Msn
- Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
- Finland · Eltrombopag Avansor, Eltrombopag Krka
- France · Eltrombopag Biogaran, Eltrombopag Eg
- United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
- Greece · Eltrombopag Anabiosis, Eltrombopag Faran
- Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
- Hungary · Elrevolan, Eltrombopag Elpen
- Ireland · Eltrombopag Clonmel, Eltrombopag Krka
- Iceland · Eltrombopag Accord, Eltrombopag Coripharma
- Italy · Elrevolan, Eltrombopag Abdi
- Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
- Lithuania · Eltrombopag Krka, Eltrombopag Msn
- Latvia · Eltrombopag Krka, Eltrombopag Olpha
- Malta · Eltrombopag Aspen, Eltrombopag Clonmel
- Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
- Norway · Eltrombopag Accord, Eltrombopag Glenmark
- Poland · Eltrombopag Glenmark, Eltrombopag Krka
- Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
- Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
- Sweden · Eltrombopag Anabiosis, Eltrombopag Avansor
- Slovenia · Eltrombopag Krka, Eltrombopag Msn
- Slovakia · Eltrombopag Glenmark, Eltrombopag Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fbca4dc3-e2d5-4f18-9e80-78e889154f9d GET /v1/drugs/fbca4dc3-e2d5-4f18-9e80-78e889154f9d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "eltrombopagum 50 mg",
"valid_from": "2026-01-01",
"limitations": "[{\"description\":\"<p><strong>Immunthrombozytopenische Purpura (ITP) – Erwachsene</strong><br>Zur Behandlung von erwachsenen Patienten mit einer mindestens 6 Monate ab Diagnose dauernden (idiopathischen) immunthrombozytopenischen Purpura (ITP), die auf andere Therapieoptionen (z.B. Kortikosteroide, Immunglobuline oder Splenektomie) nicht genügend ansprachen, bei erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie. Die Behandlung soIIte abgebrochen werden, wenn nach vierwöchiger Therapie mit 75 mg/Tag die Thrombozytenwerte nicht ausreichend ansteigen.<br>Der Indikationscode dieser Limitierung ist an den Krankenversicherer zu übermitteln.</p>\",\"costApproval\":null,\"indication\":\"22046.03\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-08-01\",\"validTo\":null},{\"description\":\"<p><strong>Immunthrombozytopenische Purpura (ITP) – Kinder ab 6 Jahren </strong><br>Zur Behandlung von pädiatrischen Patienten (6 Jahre und älter) mit einer mindestens 6 Monate ab Diagnose dauernden (idiopathischen) immunthrombozytopenischen Purpura (ITP) und relevanter Blutungsneigung, die auf eine etablierte Behandlung (z.B. IVIG, Kortikosteroide) nicht angesprochen haben und für die eine Splenektomie keine Behandlungsoption dar-stellt. Dosisreduktionen bei pädiatrischen Patienten müssen regelmässig geprüft werden.<br>Der Indikationscode dieser Limitierung ist an den Krankenversicherer zu übermitteln.</p>\\n<p> </p>\",\"costApproval\":null,\"indication\":\"22046.04\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-08-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 50 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2026-01-01",
"self_retention_pct": 10
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.